Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia

Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia

Chun Ling,1,2 Nengneng Cao,1 Huiping Wang,1 Yang Wan,1 Xue Liang,1 Jinjing Guo,1 Meng Xiao,1 Qiguo Zhang,2 Zhimin Zhai1 1Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230000, People’s Republic of China; 2Department of Hematology, Affiliated Chuzh...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ling C, Cao N, Wang H, Wan Y, Liang X, Guo J, Xiao M, Zhang Q, Zhai Z
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-01-01
Series:	International Journal of General Medicine
Subjects:	e3 ubiquitin ligase prognostic model ube2l3 acute myeloid leukemia drug resistance.
Online Access:	https://www.dovepress.com/systematic-analysis-of-e3-ligase-related-genes-identified-ube2l3-as-a--peer-reviewed-fulltext-article-IJGM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thioredoxin‐interacting protein (TXNIP) is a substrate of the NEDD4‐like E3 ubiquitin‐protein ligase WWP1 in cellular redox state regulation of acute myeloid leukemia cells
by: Sara Giovannini, et al.
Published: (2025-01-01)

NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
by: Heng Wu, et al.
Published: (2025-01-01)

E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases
by: Li Zhu, et al.
Published: (2025-02-01)

Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review
by: Chang Gao, et al.
Published: (2024-12-01)

Overview of Prognosis of FLT3 Mutations and Interactions with Other Genetic Alterations in Acute Myeloid Leukemia
by: Ayşe Gül Bayrak Tokaç, et al.
Published: (2024-12-01)

CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective
by: Makiko Nakagawa, et al.
Published: (2025-01-01)

Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai
by: Juan-José Escuder-Rodríguez, et al.
Published: (2025-01-01)

Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-02-01)

Expanding the therapeutic horizon in acute myeloid leukemia: The role of phosphoinositide-3-kinase-γ inhibition
by: Soumyajit Das, et al.
Published: (2024-12-01)

Research progress on the antiviral immune regulation of ubiquitin ligase F-box family
by: MENG Xiangbo, LI Tianqi, ZHANG Tong
Published: (2025-01-01)

Revealing the Mechanism of Protein Degradation in Postmortem Meat: The Role of Phosphorylation and Ubiquitination
by: Xinran Zhao, et al.
Published: (2025-01-01)

Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
by: Aiman B. Awan, et al.
Published: (2025-01-01)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01)

The Arabidopsis RING‐Type E3 Ligase TEAR4 Controls Seed Germination by Targeting RGA for Degradation
by: Hao Yu, et al.
Published: (2025-01-01)

基于生物信息学途径评估 UBE2 家族及 UBE2T 基因在肺腺癌中的表达及临床意义
by: 杨豪帅, et al.
Published: (2020-01-01)

Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax
by: Claudio Fozza
Published: (2024-01-01)

The fission yeast SUMO-targeted ubiquitin ligase Slx8 functionally associates with clustered centromeres and the silent mating-type region at the nuclear periphery
by: Shrena Chakraborty, et al.
Published: (2024-12-01)

ALKBH3-mediated m1A demethylation promotes the malignant progression of acute myeloid leukemia by regulating ferroptosis through the upregulation of ATF4 expression
by: Xin Liu, et al.
Published: (2025-12-01)

Impact of Hemoglobin, Leucocyte and Thrombocyte Levels at Diagnosis on the Survival Outcomes of Chronic Myeloid Leukemia Patients
by: Taha Ulutan Kars, et al.
Published: (2024-02-01)

6-month survival of patients with acute myeloid leukemia who received modified chemotherapy at Wahidin Sudirohusodo Hospital
by: Edwinda D. Ratu, et al.
Published: (2024-09-01)

Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
by: Angela Kimberly Tjahjadi, et al.
Published: (2024-10-01)

Pathological roles of ubiquitination and deubiquitination systems in sepsis-induced myocardial dysfunction
by: Zhiping Wang, et al.
Published: (2025-01-01)

Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran
by: Mahshid Heidary Sadegh, et al.
Published: (2025-01-01)

Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
by: Jinxia Cao, et al.
Published: (2025-02-01)

Spontaneous splenic rupture in a teenager as first manifestation of acute myeloid leukemia: Case report and literature review
by: Antonio Villa, et al.
Published: (2018-11-01)

Data and implication based comparison of two chronic myeloid leukemia models
by: R. A. Everett, et al.
Published: (2013-07-01)

Pathogenicity role of human herpesvirus-8 in patients with acute myeloid leukemia
by: Zahraa Ali Abdullah, et al.
Published: (2024-12-01)

A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
by: Zihan Quan, et al.
Published: (2025-12-01)

Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation
by: Kun Shi, et al.
Published: (2025-02-01)

Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
by: Yuying Zhao, et al.
Published: (2024-12-01)

Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
by: Rui Zhang, et al.
Published: (2025-02-01)

Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
by: Renshi Kawakatsu, et al.
Published: (2025-01-01)

Case report: Mucormycosis due to Rhizopus microsporus: an important reminder of opportunistic infections in immunocompromised acute myeloid leukemia
by: Misato Higuchi, et al.
Published: (2025-01-01)

Venetoclax and Azacitidine Combination is an Effective Salvage Regimen for Fit Patients with IDH-2-mutated Acute Myeloid Leukemia Refractory to Conventional Induction Chemotherapy
by: Musa Fares Alzahrani
Published: (2024-12-01)

E3 ligase RNF128 restricts A. alternata-induced ILC2 activation and type 2 immune response in the murine lung
by: Chenghua Yan, et al.
Published: (2025-01-01)

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
by: Elissa Tjahjono, et al.
Published: (2025-01-01)

A Nomogram Built on Clinical Factors and CT Attenuation Scores for Predicting Treatment Response of Acute Myeloid Leukemia Patients
by: Linna Liu, et al.
Published: (2025-01-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
by: Zahra Koolivand, et al.
Published: (2025-01-01)

Bilateral synchronous UBE for unilateral laminotomy and bilateral decompression as a potentially effective minimally Invasive approach for two-level lumbar spinal stenosis
by: Yulin Zhao, et al.
Published: (2025-01-01)